Advertisement

Uncategorized

St. Louis-based Mercy is among the first to offer a simple blood test to detect hard-to-diagnose cancers at the molecular level — before it’s too late. The test is currently available in 11 Mercy hospital labs across three states.

CMS revised their national coverage determination for durable, intracorporeal left ventricular assist devices, and the change may prevent some patients from getting heart transplants or other advanced treatments, TCTMD reported Jan. 30.

Advertisement

Here are five oncology partnerships formed since Nov. 16:

Advertisement